Skip to main content
All lobbying filings

ALLIANCE FOR REGENERATIVE MEDICINE

ALLIANCE FOR REGENERATIVE MEDICINE filed a Q4 report for ALLIANCE FOR REGENERATIVE MEDICINE on January 20, 2026.

Lobbying for ALLIANCE FOR REGENERATIVE MEDICINE · Advocacy organization supporting advances in regenerative medicine.

All filings by ALLIANCE FOR REGENERATIVE MEDICINE · Everything ALLIANCE FOR REGENERATIVE MEDICINE has reported

 Filing · LD-2 quarterly report Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Expenses
$230,000
What this organization spent lobbying with its own staff. Reported using IRS section 162(e) definitions (method C): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 6

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1
Health Issues

Advocate on issues related to regulation of, access to, and reimbursement for regenerative medicine companies and products. Value-based payment legislation and related CMS regulations. FDA appropriations and staffing. Biologics regulation. Prescription Drug User Fee Act (PDUFA). Medicaid. Medicare. Accelerating Kids Access to Care Act (S. 752 / H.R.1509). Mikaela Naylon Give Kids a Chance Act (S. 932 / H.R. 1262). Rare Pediatric Disease Priority Review Vouchers. Bipartisan Health Care Act (S. 891). MVP Act (S.1637). NIH appropriations. HHS oversight. HHS staffing and OPM issues. Medical research. Pharmaceutical tariffs. Biotechnology manufacturing. Newborn screening. FDA oversight.

 Bills named in this filing 6
  • S. 752
    Accelerating Kids’ Access to Care Act
  • H.R. 1509
    Accelerating Kids’ Access to Care Act of 2025
  • S. 932
    Give Kids a Chance Act of 2025
  • H.R. 1262
    Mikaela Naylon Give Kids a Chance Act
  • S. 891
    Bipartisan Health Care Act
  • S. 1637
    MVP Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem